Expression of mos in astrocytic tumors and its potential role in neoplastic progression.

Autor: Perunovic B; Department of Neuropathology, Frenchay Hospital, Bristol, United Kingdom., Athanasiou A, Quilty RD, Gorgoulis VG, Kittas C, Love S
Jazyk: angličtina
Zdroj: Human pathology [Hum Pathol] 2002 Jul; Vol. 33 (7), pp. 703-7.
DOI: 10.1053/hupa.2002.125377
Abstrakt: The c-mos gene and its protein product mos, components of the mitogen-activated protein kinase transduction pathway, are known to be involved in the control of meiosis and mitosis. Apart from a study on lung carcinomas, there is little information about its role in human neoplasia. The aim of this study was to investigate expression of mos in astrocytic tumors and to correlate it with accumulation of p53. We studied expression of mos in 62 cases of supratentorial astrocytic tumor. Intracytoplasmic immunostaining for mos was found in 28 (45%) cases: 3 of 20 (15%) grade 2 astrocytomas, 9 of 20 (45%) grade 3 anaplastic astrocytomas, and 16 of 22 (73%) glioblastomas. Immunopositivity for mos correlated significantly (P < 0.01) with tumor grade but not with p53 expression. In contrast to the findings in relation to lung tumors, immunopositivity for mos in astrocytic tumors did not predict recurrence-free or overall survival time. Cytoplasmic immunostaining was observed in scattered large cortical neurons adjacent to tumors, possibly due to stress-induced abortive entry into the cell cycle. The correlation of mos immunopositivity with tumor grade may reflect the expansion of more malignant mos-positive clones. This study provides evidence that mos may be involved in the neoplastic progression of a proportion of astrocytic tumors.
(Copyright 2002, Elsevier Science (USA). All rights reserved.)
Databáze: MEDLINE
Externí odkaz: